RESUMO
A high prevalence of low bone mineralization is documented in adult patients with cystic fibrosis (CF). Osteopenia is present in as much as 85% of adult patients and osteoporosis in 13 to 57% of them. In children, studies are discordant probably because of different control database. Denutrition, inflammation, vitamin D and vitamin K deficiency, altered sex hormone production, glucocorticoid therapy, and physical inactivity are well known risk factors for poor bone health. Puberty is a critical period and requires a careful follow-up for an optimal bone peak mass. This review is a consensus statement established by the national working group of the French Federation of CF Centers to develop practice guidelines for optimizing bone health in patients with CF. Recommendations for screening and for calcium, vitamin D and K supplementation are given. Further work is needed to define indications for treatment with biphosphonates and anabolic agents.
Assuntos
Desmineralização Patológica Óssea/etiologia , Desmineralização Patológica Óssea/terapia , Fibrose Cística/complicações , Osteoporose/etiologia , Adolescente , Desmineralização Patológica Óssea/epidemiologia , Densidade Óssea , Cálcio/metabolismo , Criança , Pré-Escolar , Exercício Físico , Feminino , Humanos , Absorção Intestinal , Masculino , Estado Nutricional , Osteoporose/epidemiologia , Osteoporose/terapia , Puberdade , Vitamina D/uso terapêuticoRESUMO
Itraconazole diffusion in sputum was studied in 11 cystic fibrosis patients with allergic bronchopulmonary aspergillosis. There was a high interindividual variability in sputum itraconazole concentration and sputum/serum drug concentration ratio. Three children had sputum drug concentrations before oral administration that were lower than the itraconazole MIC at which 90% of Aspergillus fumigatus strains were inhibited, although their serum drug concentrations were within the therapeutic range.